Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Metformin
Metformin
Routinely available
Local application
25/05/2022
Indication
For use in weight gain associated with antipsychotic treatment.
Therapeutic Area
Central nervous system
Status Description
Routinely available in line with local or regional guidance
Formulation
500mg tablets
Comments
May 2022 - Routinely available in line with local guidance. Included on the ERF for Specialist initiation. Classified for use under policy for the use of unlicensed medicines.